RIGEL PHARMACEUTICALS INC·4

Jan 25, 6:36 PM ET

Mayer Eldon C. III 4

4 · RIGEL PHARMACEUTICALS INC · Filed Jan 25, 2019

Insider Transaction Report

Form 4
Period: 2019-01-23
Mayer Eldon C. III
EVP &Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-01-23+200,000200,000 total
    Exercise: $2.00Exp: 2029-01-23Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -